Tech Center 1600 • Art Units: 1629
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18448559 | COMBINATION THERAPIES FOR TREATMENT OF CIRRHOSIS WITH PORTAL HYPERTENSION | Non-Final OA | AstraZeneca AB |
| 17923891 | METHODS FOR INDUCING BILE ACID SULFOTRANSFERASE SULT2A FOR TREATING METABOLIC DISORDERS | Non-Final OA | The Brigham and Women's Hospital, Inc. |
| 18232970 | TRICYCLIC TRIAZOLO COMPOUNDS AS DGK INHIBITORS | Non-Final OA | Incyte Corporation |
| 18353770 | BIARYL ETHER UREA COMPOUNDS | Non-Final OA | Jazz Pharmaceuticals Ireland Limited |
| 18286068 | COMPOUND FOR PREVENTING OR TREATING DIABETES | Non-Final OA | ONCOCROSS CO., LTD. |
| 18230686 | BIPHENYL SULFONAMIDES AS DUAL ANGIOTENSIN ENDOTHELIN RECEPTOR ANTAGONISTS | Non-Final OA | Chongqing Hongyuantang Medicine Co., Ltd. |
| 18363123 | ANTI-INFLAMMATORY COMPOSITION COMPRISING N-BENZYL-N-METHYLDECAN-1-AMINE OR A DERIVATIVE THEREOF AS AN ACTIVE INGREDIENT | Non-Final OA | HaYoung Meditech Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy